Literature DB >> 20937310

Population and risk group uptake of H1N1 influenza vaccine in mainland France 2009-2010: results of a national vaccination campaign.

Angie Bone1, Jean-Paul Guthmann, Javier Nicolau, Daniel Lévy-Bruhl.   

Abstract

A mass vaccination campaign against influenza A/H1N1 was launched in France in October 2009. Vaccination was offered free of charge to the entire population according to a pre-defined order of priority. Demographic data and data on vaccinations given were recorded in a dedicated database. We analysed vaccine uptake by age, sex and region in the overall population and in certain risk groups, including pregnant women. Overall vaccine uptake was 8% and varied by age-group and sex. Vaccine uptake in pregnant women was 22.7%. These low uptakes may reflect controversies around the vaccine and vaccination policy and have important implications for future pandemic vaccination strategies.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20937310     DOI: 10.1016/j.vaccine.2010.09.096

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  32 in total

1.  Fatal outcome of pandemic H1N1 2009 influenza virus infection is associated with immunopathology and impaired lung repair, not enhanced viral burden, in pregnant mice.

Authors:  Glendie Marcelin; Jerry R Aldridge; Susu Duan; Hazem E Ghoneim; Jerold Rehg; Henju Marjuki; Adrianus C M Boon; Jonathan A McCullers; Richard J Webby
Journal:  J Virol       Date:  2011-08-24       Impact factor: 5.103

2.  Neighborhood determinants of 2009 pandemic A/H1N1 influenza vaccination in Montreal, Quebec, Canada.

Authors:  Stephanie Brien; Jeffrey C Kwong; Katia M Charland; Aman D Verma; John S Brownstein; David L Buckeridge
Journal:  Am J Epidemiol       Date:  2012-10-16       Impact factor: 4.897

3.  Pandemic influenza vaccination during pregnancy: an investigation of vaccine uptake during the 2009/10 pandemic vaccination campaign in Great Britain.

Authors:  Cormac J Sammon; Anita McGrogan; Julia Snowball; Corinne S de Vries
Journal:  Hum Vaccin Immunother       Date:  2013-01-30       Impact factor: 3.452

Review 4.  Strategies implemented to address vaccine hesitancy in France: A review article.

Authors:  Cécile Fokoun
Journal:  Hum Vaccin Immunother       Date:  2018-06-14       Impact factor: 3.452

5.  Acceptance and rejection of influenza vaccination by pregnant women in southern Iran: physicians' role and barriers.

Authors:  Behnam Honarvar; Neda Odoomi; Mojtaba Mahmoodi; Golnar Sami Kashkoli; Fatemeh Khavandegaran; Kamran Bagheri Lankarani; Mohsen Moghadami
Journal:  Hum Vaccin Immunother       Date:  2012-10-02       Impact factor: 3.452

6.  First French experience of ADR reporting by patients after a mass immunization campaign with Influenza A (H1N1) pandemic vaccines: a comparison of reports submitted by patients and healthcare professionals.

Authors:  Geneviève Durrieu; Aurore Palmaro; Laure Pourcel; Céline Caillet; Angeline Faucher; Alexis Jacquet; Shéhérazade Ouaret; Marie Christine Perault-Pochat; Carmen Kreft-Jais; Anne Castot; Maryse Lapeyre-Mestre; Jean-Louis Montastruc
Journal:  Drug Saf       Date:  2012-10-01       Impact factor: 5.606

Review 7.  Review on the impact of pregnancy and obesity on influenza virus infection.

Authors:  Erik A Karlsson; Glendie Marcelin; Richard J Webby; Stacey Schultz-Cherry
Journal:  Influenza Other Respir Viruses       Date:  2012-02-15       Impact factor: 4.380

8.  The PREGVAXGRIP study: a cohort study to assess foetal and neonatal consequences of in utero exposure to vaccination against A(H1N1)v2009 influenza.

Authors:  F Chavant; I Ingrand; A P Jonville-Bera; C Plazanet; V Gras-Champel; L Lagarce; M Zenut; A Disson-Dautriche; S Logerot; M Auffret; A Coubret-Dumas; M L Bruel; M Boyer; M A Bos-Thompson; G Veyrac; P Carlier; M N Beyens; S Lates; C Damase-Michel; A Castot; C Kreft-Jaïs; M C Pérault-Pochat
Journal:  Drug Saf       Date:  2013-06       Impact factor: 5.606

9.  Willingness to Be Vaccinated against COVID-19 in Spain before the Start of Vaccination: A Cross-Sectional Study.

Authors:  Noelia Rodríguez-Blanco; Sergio Montero-Navarro; José M Botella-Rico; Antonio J Felipe-Gómez; Jesús Sánchez-Más; José Tuells
Journal:  Int J Environ Res Public Health       Date:  2021-05-15       Impact factor: 3.390

10.  Influenza Vaccine Coverage among Pregnant Women in a Public Hospital System during the 2009-2010 Pandemic Influenza Season.

Authors:  Dean V Coonrod; Blanca-Flor Jimenez; Amber N Sturgeon; David Drachman
Journal:  Influenza Res Treat       Date:  2012-05-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.